Dr. Kai Lamottke | Managing Director
Kai Lamottke is co-founder of Bicoll GmbH, Munich where he holds a position as Managing Director. Since 2001 he is also appointed as General Manager and member of the Board of Directors of Bicoll Biotechnology (Shanghai) Co. Ltd. In his position Dr. Lamottke is responsible for initial client and partnership contacts.
Prior to joining Bicoll he was working for the rational drug discovery company, 4SC AG, establishing the combinatorial chemistry division as project leader.
Dr. Lamottke received his Ph.D.-grade from the University of Munich working on the total synthesis and biosynthesis of medical relevant natural active agents.
Prof. Dr. Yang Ye | Vice Chairman of Board of Directors
Yang Ye is co-founder of Bicoll GmbH, Munich. In 2001 he was appointed Vice Chairman of the Board of Directors for Bicoll Biotechnology (Shanghai) Co. Ltd..
Dr. Ye also holds a position as professor of State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences. As a member of Bicoll's Board of Directors in Shanghai he provides input in special academia related topics.
He gained international experiences in this specific field with the Bayer Central Research Department, Leverkusen, Germany and his postdoctoral position at the Institute of Organic Chemistry, University of Munich, Germany. Prof. Ye finished his Ph. D. degree in Chemistry at SIMM specializing in natural products chemistry in 1992. His research led to several publications in international media.
Maria Lamottke | Public Relations Management
Maria Lamottke joined Bicoll GmbH, Munich and Bicoll Biotechnology (Shanghai) Co. Ltd. as Public Relations Manager in December 2010. Maria Lamottke has a profound finance as well as investor relations background. She received her Ph.D. in finance and diploma in finance and credit working on households portfolio optimization and gained special insights in the investor relations at the stock market company in Russia.